Informed Consent and Antipsychotic Use in Patients with Schizophrenia: Issues and Recommendations

ISSN： 1172-7047

Source： CNS Drugs, Vol.9, Iss.1, 1998-01, pp. : 1-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inclusion of Patients with Severe Mental Illness in Clinical Trials: Issues and Recommendations Surrounding Informed Consent

By Welie Sander P.K. Berghmans Ron L.P.

CNS Drugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 67-83

Adis International

Access to resources Recommend Favorite

Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia

By Lin Jay

The Journal of Behavioral Health Services & Research, Vol. 40, Iss. 3, 2013-07 ,pp. : 355-366

Springer Publishing Company

Access to resources Recommend Favorite

Informed Consent and Informed Refusal

By WAGNER RICHARD F. TORRES ABEL PROPER STEVEN

Dermatologic Surgery, Vol. 21, Iss. 6, 1995-06 ,pp. : 555-559

Elsevier

Access to resources Recommend Favorite

Informed consent in medical research

By Evans John Grimley Beck Peter

Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. : 267-272

Royal College Of Physicians

Access to resources Recommend Favorite

Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment

By Minutolo Giuseppe Petralia Antonino Dipasquale Salvatore Aguglia Eugenio

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 1989-1997

Informa Healthcare

Access to resources Recommend Favorite